At CES 2026, Bluetti unveils its new energy solutions for home and road: Elite 100 V2 Bio-Based, Elite 300, Elite 400, ...
Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...
Bristol-Myers Squibb's Celgene unit has clearly been impressed by progress in its four-year-old alliance with Evotec on protein degradation. It's just paid $200 million to extend the partnership for ...
Bluetti’s latest car charger can quickly charge power stations at a very fast 1200W — about 10 times faster than plugging it ...
Born from EV technology, this electronic brake booster is quietly transforming how vintage performance cars stop—and why ...
In 1531 a "Lady from Heaven" appeared to Saint Juan Diego, a poor Indian from Tepeyac, a hill northwest of Mexico City. She identified herself as the Mother of the True God and instructed him to have ...